Pharmaceutico Analytical Study of Avipattikara Churna and Avipattikara Suspension and their Comparative Clinical Evaluation in Amlapitta with Special Reference to Functional Dyspepsia.

ational Institute of ayurveda jaipur0 sites0 target enrollmentStarted: TBDLast updated: October 16, 2023

Trial Snapshot

No summary available.

•Subject fulfilling the Rome IV criteria (2016) for Functional Dyspepsia.
•Criteria fulfilled for the last 3 months with symptom onset, at least 6 months prior to diagnosis with one or more of the following symptoms: upper abdominal pain (epigastric pain) or discomfort, postprandial fullness, early satiation, bloating, nausea and belching.

•Any kind of organic lesion such as peptic ulcer, tumor of any kind, stricture, or structural deformity.
•Subject with known history of gastric bleeding, intestinal obstruction or perforation, and previous gastrointestinal surgery.
•? Subjects with major systemic illness including cardiac disease, diabetes, hypertension, inflammatory bowel disease etc.
•? Patients on prolonged (=6 weeks) medication with corticosteroids, antidepressants, anticholinergics, etc., or any other drugs that may have an influence on the outcome of the study like antacids or PPI.
•? Subjects currently taking drugs that may affect gastrointestinal motility (e.g., anticholinergic, erythromycin, azithromycin, domperidone, etc.), nonsteroidal anti-inflammatory drugs.
•? Patients with a history of hypersensitivity to any of the trial drugs or their ingredients.

Sponsor

ational Institute of ayurveda jaipur